Latest News
-
B. Braun and Philips join forces to innovate in ultrasound-guided regional anesthesia and vascular access
Strategic alliance combines B. Braun’s leadership in regional anesthesia and Philips’ leadership in image guided therapy solutions with the aim to make regional anesthesia and vascular access easier to perform, leading to enhanced patient care and hospital efficiency. Xperius* is the new mobile ultrasound system specifically designed as the platform to support current and future integrated solutions in ultrasound-guided regional anesthesia.
-
B. Braun continues its sales and earnings growth
B. Braun Melsungen AG has successfully completed the 2016 financial year.
-
Change in the B. Braun Management Board
Melsungen. Mr. Otto Philipp Braun and B. Braun Melsungen AG have mutually agreed on his resignation as member of the Management Board on best and mutual terms, effective February 21, 2017.
-
B. Braun Medical to Present Comprehensive Parenteral Nutrition Program at ASPEN’s Clinical Nutrition Week
BETHLEHEM, PA – February 14, 2017 — B. Braun Medical Inc., a leader in customized parenteral nutrition, will present its new parenteral nutrition program – PN360 – designed to improve neonatal, pediatric and adult patient outcomes — at this year’s American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Clinical Nutrition Week.
-
B. Braun Medical's Outlook® Pump Completes Systems Integration with Iatric Systems Accelero Connect®
B. Braun Medical Inc. has successfully completed systems integration of its Outlook® large-volume infusion pump with Iatric Systems Inc. Accelero Connect® integration software, enabling the pump to communicate with a number of EHR solutions, including MEDITECH.
-
B. Braun Medical to Introduce Comprehensive Parenteral Nutrition Program at ASHP
BETHLEHEM, PA – B. Braun Medical Inc. will introduce its new Parenteral Nutrition 360 (PN360) program — designed to improve neonatal, pediatric and adult patient outcomes.
-
B. Braun Launches Prontosan® Wound Gel X
BETHLEHEM, PA Only wound gel with Betaine and Polyhexanide – two ingredients designed to keep wounds clean.
-
B. Braun to Present New Line of Echogenic Peripheral Nerve Block Needles at American Society of Anesthesiologists Meeting
B. Braun Medical Inc will demonstrate the advantages of its new echogenic peripheral nerve block needle technology.
-
B. Braun to Launch Neuraxial Products with NRFit Connectors at American Society of Anesthesiologists Meeting
B. Braun Medical Inc. will launch a new patient safety initiative – its neuraxial products with NRFit™ connectors
-
B. Braun Platinum Sponsor at AdvaMed 2016 MedTech Conference
B. Braun Medical Inc. will serve as a platinum sponsor at this year’s Advanced Medical Technology Association conference.
-
B. Braun Medical Sponsors Practice Greenhealth’s PVC – DEHP Free Award at CleanMed 2016
Bon Secours St. Francis Health System recognized for commitment to eco-friendly products
-
B. Braun Medical acquires Dismed’s hand sanitizer and intravenous fluid businesses in South Africa
Commitment to growth and local manufacturing for the African healthcare sector
-
IFC Supports B. Braun Melsungen`s local pharmaceuticals manufacturing in Indonesia
The member of World Bank Group provides a loan to B. Braun Melsungen AG operations in Indonesia.
-
B. Braun Medical Inc. and Affiliates Sue Becton, Dickinson & Co. for IV Catheter Safety Mechanism Patent Infringements
Lawsuit filed against Becton, Dickinson and Company and Becton Dickinson Infusion Therapy Systems Inc. for infringing 10 U.S. patents
-
B. Braun's growth trend continues
All divisions contributed to the positive sales development of the Group
-
Change in B. Braun Management Board
As of April 1, 2016 Anna Maria Braun, President of the Asia/Pacific region, joins the management board.
-
B. Braun Avitum receives the Best Employer Award in Hungary
The companies were assessed in the categories satisfaction and engagement of employees, company reputation, attraction and employer brand.
-
B. Braun acquires DTZ Dialyse Trainings-Zentren GmbH
DTZ operates fourteen renal care centers in Germany, three in Austria, and one in Italy.
-
Successful patient recruitment in the CONSEQUENT Trial
The CONSEQUENT Trial investigated B. Braun’s novel peripheral drug coated balloon technology SeQuent® Please OTW.
-
Best results in the company's history kick off B. Braun’s anniversary year
Plus a record € 1 billion in investments